Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Lung Neoplasms 1Leukemia 1Glioblastoma 1Disease 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Cancer 1

Interventions

apatinib 8Paclitaxel 7Capecitabine 7Oxaliplatin 6Cisplatin 5camrelizumab 4S 1 (combination) 3Fluorouracil 3130-nm albumin-bound paclitaxel 3Leucovorin 2Drug Therapy 2Docetaxel 2trifluridine tipiracil drug combination 1titanium silicide 1tipiracil 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1ezogabine 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1Sunitinib 1SHR-1701 1Ramucirumab 1Metabolic Networks and Pathways 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Gastric Cancer × Drug Therapy, Combination × Clear all
NCT06376773 2024-04-19

Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.

Fujian Medical University

Completed
234 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡